SCHEMBL23409186

SCHEMBL23409186

CCCCC/C=C\C/C=C\CCCCCCCC(C)C1=NC(C)(C)CO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.35
ALDH1A1 P00352 4/20 0.35
F7 P08709 3/20 0.35
F3 P13726 3/20 0.35
PPARG P37231 2/20 0.35
PPARD Q03181 2/20 0.35
PPARA Q07869 2/20 0.35
DUSP3 P51452 1/20 0.35
PTPN7 P35236 1/20 0.35
KDM4E B2RXH2 1/20 0.35
FFAR1 O14842 1/20 0.35
LMNA P02545 1/20 0.35
FABP3 P05413 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP19A1 P11511 1/20 0.35
FABP4 P15090 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23198744 0.78 TRPV1 (0.39) TRPV1ALDH1A1F7F3PPARG
SCHEMBL10817501 0.75 ABCG2 (0.32)
SCHEMBL23409187 0.73 CNR1 (0.37) TRPV1ALDH1A1F7F3PPARG
SCHEMBL677207 0.73 EPHX2 (0.39) TRPV1ALDH1A1LMNACYP3A4ALOX15
SCHEMBL8988091 0.70 FFAR1 (0.49) TRPV1ALDH1A1KDM4EFFAR1CYP3A4
SCHEMBL11250690 0.68 TRPV1 (0.50) TRPV1ALDH1A1F7F3PPARG
SCHEMBL11250694 0.68 TRPV1 (0.50) TRPV1ALDH1A1F7F3PPARG
SCHEMBL24719582 0.68 TRPV1 (0.53) TRPV1ALDH1A1F7F3PPARG
SCHEMBL11869444 0.68 TRPV1 (0.53) TRPV1ALDH1A1F7F3PPARG
SCHEMBL11869451 0.68 TRPV1 (0.53) TRPV1ALDH1A1F7F3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210155640-A1 LINOLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID LINOLEIC ACID DERIVATIVES, AND THEIR USES EKTAH (FR) 2021-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155640-A1 LINOLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID LINOLEIC ACID DERIVATIVES, AND THEIR USES ALOX15, ALOX12, ALOX15B TRPV1 1576/4885ALDH1A1 282/4885F7 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.